Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

TRAF2 and FKBP51 as possible markers for identification of suitable melanoma tumors for tumor necrosis factor-α inhibition.

Romano S, D'Arrigo P, Tufano M, Staibano S, Rea A, Merolla F, Ilardi G, Petrella A, Romano MF.

Melanoma Res. 2018 Nov 19. doi: 10.1097/CMR.0000000000000553. [Epub ahead of print]

PMID:
30451787
2.

Manipulation of the immune system for cancer defeat: a focus on the T cell inhibitory checkpoint molecules.

D'Arrigo P, Tufano M, Rea A, Vigorito V, Novizio N, Russo S, Romano MF, Romano S.

Curr Med Chem. 2018 Nov 5. doi: 10.2174/0929867325666181106114421. [Epub ahead of print]

PMID:
30398102
3.

Prognostic Value of a Tissue Doppler Index of Systodiastolic Function in Patients with Asymptomatic Heart Failure.

Pugliese NR, Fabiani I, La Carrubba S, Carerj S, Conte L, Colonna P, Caso P, Benedetto F, Antonini-Canterin F, Romano MF, Citro R, Di Bello V; Italian Society of Cardiovascular Echography (SIEC).

J Cardiovasc Echogr. 2018 Apr-Jun;28(2):95-100. doi: 10.4103/jcecho.jcecho_59_17.

4.

Tirofiban Positively Regulates β1 Integrin and Favours Endothelial Cell Growth on Polylactic Acid Biopolymer Vascular Scaffold (BVS).

Giordano A, Romano S, Corcione N, Frati G, Zoccai GB, Ferraro P, Messina S, Ottolini S, Romano MF.

J Cardiovasc Transl Res. 2018 Jun;11(3):201-209. doi: 10.1007/s12265-018-9805-1. Epub 2018 Apr 25.

PMID:
29696533
5.

A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma.

D'Arrigo P, Russo M, Rea A, Tufano M, Guadagno E, Del Basso De Caro ML, Pacelli R, Hausch F, Staibano S, Ilardi G, Parisi S, Romano MF, Romano S.

Oncotarget. 2017 Jul 17;8(40):68291-68304. doi: 10.18632/oncotarget.19309. eCollection 2017 Sep 15.

6.

Expression of FK506-binding protein 51 (FKBP51) in Mycosis fungoides.

Mascolo M, Romano MF, Ilardi G, Romano S, Baldo A, Scalvenzi M, Argenziano G, Merolla F, Russo D, Varricchio S, Pagliuca F, Russo M, Ciancia G, De Rosa G, Staibano S.

J Eur Acad Dermatol Venereol. 2018 May;32(5):735-744. doi: 10.1111/jdv.14614. Epub 2017 Nov 9.

PMID:
28977697
7.

Incremental prognostic value of a complex left ventricular remodeling classification in asymptomatic for heart failure hypertensive patients.

Fabiani I, Pugliese NR, La Carrubba S, Conte L, Antonini-Canterin F, Colonna P, Benedetto F, Calogero E, Barletta V, Carerj S, Buralli S, Taddei S, Romano MF, Di Bello V; Italian Society of Cardiovascular Echography (SIEC).

J Am Soc Hypertens. 2017 Jul;11(7):412-419. doi: 10.1016/j.jash.2017.05.005. Epub 2017 May 25.

PMID:
28619598
8.

FKBP51s signature in peripheral blood mononuclear cells of melanoma patients as a possible predictive factor for immunotherapy.

Romano S, Simeone E, D'Angelillo A, D'Arrigo P, Russo M, Capasso M, Lasorsa VA, Zambrano N, Ascierto PA, Romano MF.

Cancer Immunol Immunother. 2017 Sep;66(9):1143-1151. doi: 10.1007/s00262-017-2004-0. Epub 2017 Apr 22.

PMID:
28434031
9.

FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?

Russo D, Merolla F, Mascolo M, Ilardi G, Romano S, Varricchio S, Napolitano V, Celetti A, Postiglione L, Di Lorenzo PP, Califano L, Dell'Aversana GO, Astarita F, Romano MF, Staibano S.

Int J Mol Sci. 2017 Feb 18;18(2). pii: E443. doi: 10.3390/ijms18020443.

10.

Comparison of Biolimus Versus Everolimus for Drug-Eluting Stents in the Percutaneous Treatment of Infra-Inguinal Arterial Disease.

Giordano A, Ferraro P, Corcione N, Messina S, Maresca G, Coscioni E, Avellino R, Giordano G, Peruzzi M, Marullo AGM, Napolitano G, Romano MF, Biondi-Zoccai G.

Curr Vasc Pharmacol. 2017;15(3):257-264. doi: 10.2174/1570161115666170123094523.

PMID:
28117007
11.

Classification and Prognostic Evaluation of Left Ventricular Remodeling in Patients With Asymptomatic Heart Failure.

Pugliese NR, Fabiani I, La Carrubba S, Conte L, Antonini-Canterin F, Colonna P, Caso P, Benedetto F, Santini V, Carerj S, Romano MF, Citro R, Di Bello V; Italian Society of Cardiovascular Echography (SIEC).

Am J Cardiol. 2017 Jan 1;119(1):71-77. doi: 10.1016/j.amjcard.2016.09.018. Epub 2016 Sep 29.

PMID:
27776801
12.

Inhibition of PID1/NYGGF4/PCLI1 gene expression highlights its role in the early events of the cell cycle in NIH3T3 fibroblasts.

Monteleone F, Vitale M, Caratù G, D'Ambrosio C, Di Giovanni S, Gorrese M, Napolitano F, Romano MF, Del Vecchio L, Succoio M, Scaloni A, Zambrano N.

J Enzyme Inhib Med Chem. 2016;31(sup4):45-53. Epub 2016 Aug 17.

PMID:
27535298
13.

Web Health Monitoring Survey: A New Approach to Enhance the Effectiveness of Telemedicine Systems.

Romano MF, Sardella MV, Alboni F.

JMIR Res Protoc. 2016 Jun 6;5(2):e101. doi: 10.2196/resprot.5187.

14.

Tirofiban counteracts endothelial cell apoptosis through the VEGF/VEGFR2/pAkt axis.

Giordano A, Romano S, D'Angelillo A, Corcione N, Messina S, Avellino R, Biondi-Zoccai G, Ferraro P, Romano MF.

Vascul Pharmacol. 2016 May;80:67-74. doi: 10.1016/j.vph.2015.12.001. Epub 2015 Dec 15.

PMID:
26699078
15.

Effects Of Glycoprotein IIb/IIIa Antagonists: Anti Platelet Aggregation And Beyond.

Giordano A, Musumeci G, D'Angelillo A, Rossini R, Zoccai GB, Messina S, Coscioni E, Romano S, Romano MF.

Curr Drug Metab. 2016;17(2):194-203. Review.

PMID:
26652157
16.

Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death.

Narayanan KB, Ali M, Barclay BJ, Cheng QS, D'Abronzo L, Dornetshuber-Fleiss R, Ghosh PM, Gonzalez Guzman MJ, Lee TJ, Leung PS, Li L, Luanpitpong S, Ratovitski E, Rojanasakul Y, Romano MF, Romano S, Sinha RK, Yedjou C, Al-Mulla F, Al-Temaimi R, Amedei A, Brown DG, Ryan EP, Colacci A, Hamid RA, Mondello C, Raju J, Salem HK, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Kim SY, Bisson WH, Lowe L, Park HH.

Carcinogenesis. 2015 Jun;36 Suppl 1:S89-110. doi: 10.1093/carcin/bgv032. Review.

17.

Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.

Goodson WH 3rd, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK, Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, Zhou BP, Blanco-Aparicio C, Baglole CJ, Dong C, Mondello C, Hsu CW, Naus CC, Yedjou C, Curran CS, Laird DW, Koch DC, Carlin DJ, Felsher DW, Roy D, Brown DG, Ratovitski E, Ryan EP, Corsini E, Rojas E, Moon EY, Laconi E, Marongiu F, Al-Mulla F, Chiaradonna F, Darroudi F, Martin FL, Van Schooten FJ, Goldberg GS, Wagemaker G, Nangami GN, Calaf GM, Williams G, Wolf GT, Koppen G, Brunborg G, Lyerly HK, Krishnan H, Ab Hamid H, Yasaei H, Sone H, Kondoh H, Salem HK, Hsu HY, Park HH, Koturbash I, Miousse IR, Scovassi AI, Klaunig JE, Vondráček J, Raju J, Roman J, Wise JP Sr, Whitfield JR, Woodrick J, Christopher JA, Ochieng J, Martinez-Leal JF, Weisz J, Kravchenko J, Sun J, Prudhomme KR, Narayanan KB, Cohen-Solal KA, Moorwood K, Gonzalez L, Soucek L, Jian L, D'Abronzo LS, Lin LT, Li L, Gulliver L, McCawley LJ, Memeo L, Vermeulen L, Leyns L, Zhang L, Valverde M, Khatami M, Romano MF, Chapellier M, Williams MA, Wade M, Manjili MH, Lleonart ME, Xia M, Gonzalez MJ, Karamouzis MV, Kirsch-Volders M, Vaccari M, Kuemmerle NB, Singh N, Cruickshanks N, Kleinstreuer N, van Larebeke N, Ahmed N, Ogunkua O, Krishnakumar PK, Vadgama P, Marignani PA, Ghosh PM, Ostrosky-Wegman P, Thompson PA, Dent P, Heneberg P, Darbre P, Sing Leung P, Nangia-Makker P, Cheng QS, Robey RB, Al-Temaimi R, Roy R, Andrade-Vieira R, Sinha RK, Mehta R, Vento R, Di Fiore R, Ponce-Cusi R, Dornetshuber-Fleiss R, Nahta R, Castellino RC, Palorini R, Abd Hamid R, Langie SA, Eltom SE, Brooks SA, Ryeom S, Wise SS, Bay SN, Harris SA, Papagerakis S, Romano S, Pavanello S, Eriksson S, Forte S, Casey SC, Luanpitpong S, Lee TJ, Otsuki T, Chen T, Massfelder T, Sanderson T, Guarnieri T, Hultman T, Dormoy V, Odero-Marah V, Sabbisetti V, Maguer-Satta V, Rathmell WK, Engström W, Decker WK, Bisson WH, Rojanasakul Y, Luqmani Y, Chen Z, Hu Z.

Carcinogenesis. 2015 Jun;36 Suppl 1:S254-96. doi: 10.1093/carcin/bgv039. Review. Erratum in: Carcinogenesis. 2016 Mar;37(3):344.

18.

FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma.

Romano S, Xiao Y, Nakaya M, D'Angelillo A, Chang M, Jin J, Hausch F, Masullo M, Feng X, Romano MF, Sun SC.

Nucleic Acids Res. 2015 Aug 18;43(14):6983-93. doi: 10.1093/nar/gkv615. Epub 2015 Jun 22.

19.

Molecular Aspects of FKBP51 that Enable Melanoma Dissemination.

D'Angelillo A, Staibano S, Russo M, Romano MF, Romano S.

Curr Mol Pharmacol. 2015;9(2):141-7. Review.

PMID:
25986563
20.

Immunomodulatory pathways regulate expression of a spliced FKBP51 isoform in lymphocytes of melanoma patients.

Romano S, D'Angelillo A, Staibano S, Simeone E, D'Arrigo P, Ascierto PA, Scalvenzi M, Mascolo M, Ilardi G, Merolla F, Jovarauskaite E, Romano MF.

Pigment Cell Melanoma Res. 2015 Jul;28(4):442-52. doi: 10.1111/pcmr.12378. Epub 2015 May 13.

PMID:
25895097
21.

Pleiotropic roles in cancer biology for multifaceted proteins FKBPs.

Romano S, D'Angelillo A, Romano MF.

Biochim Biophys Acta. 2015 Oct;1850(10):2061-8. doi: 10.1016/j.bbagen.2015.01.004. Epub 2015 Jan 13. Review.

PMID:
25592270
22.

Is the digital divide an obstacle to e-health? An analysis of the situation in Europe and in Italy.

Romano MF, Sardella MV, Alboni F, Russo L, Mariotti R, Nicastro I, Barletta V, Di Bello V.

Telemed J E Health. 2015 Jan;21(1):24-35. doi: 10.1089/tmj.2014.0010. Epub 2014 Dec 11.

PMID:
25495564
23.

miR-23a, miR-24 and miR-27a protect differentiating ESCs from BMP4-induced apoptosis.

Musto A, Navarra A, Vocca A, Gargiulo A, Minopoli G, Romano S, Romano MF, Russo T, Parisi S.

Cell Death Differ. 2015 Jun;22(6):1047-57. doi: 10.1038/cdd.2014.198. Epub 2014 Dec 5.

24.

Tirofiban induces VEGF production and stimulates migration and proliferation of endothelial cells.

Giordano A, D'Angelillo A, Romano S, D'Arrigo P, Corcione N, Bisogni R, Messina S, Polimeno M, Pepino P, Ferraro P, Romano MF.

Vascul Pharmacol. 2014 May-Jun;61(2-3):63-71. doi: 10.1016/j.vph.2014.04.002. Epub 2014 Apr 18.

PMID:
24751361
25.

The informative contribution of the "virtual medical visit" in a new heart failure telemedicine integrated system.

Romano MF, Sardella MV, Alboni F, L'Abbate A, Mariotti R, Di Bello V.

Telemed J E Health. 2014 Jun;20(6):508-21. doi: 10.1089/tmj.2013.0225. Epub 2014 Apr 8.

PMID:
24712556
26.

FKBP51 increases the tumour-promoter potential of TGF-beta.

Romano S, D'Angelillo A, D'Arrigo P, Staibano S, Greco A, Brunetti A, Scalvenzi M, Bisogni R, Scala I, Romano MF.

Clin Transl Med. 2014 Jan 27;3(1):1. doi: 10.1186/2001-1326-3-1.

27.

Translational control in the stress adaptive response of cancer cells: a novel role for the heat shock protein TRAP1.

Matassa DS, Amoroso MR, Agliarulo I, Maddalena F, Sisinni L, Paladino S, Romano S, Romano MF, Sagar V, Loreni F, Landriscina M, Esposito F.

Cell Death Dis. 2013 Oct 10;4:e851. doi: 10.1038/cddis.2013.379.

28.

Role of electrocardiography and echocardiography in prevention and predicting outcome of subjects at increased risk of heart failure.

Di Bello V, La Carrubba S, Antonini-Canterin F, Di Salvo G, Caso P, La Canna G, Erlicher A, Badano L, Romano MF, Zito C, Vriz O, Conte L, Carerj S; Research Group of the Italian Society of Cardiovascular Echography (SIEC), Milan, Italy.

Eur J Prev Cardiol. 2015 Feb;22(2):249-62. doi: 10.1177/2047487313508343. Epub 2013 Oct 8.

PMID:
24104888
29.

Somatic overgrowth predisposes to seizures in autism spectrum disorders.

Valvo G, Baldini S, Brachini F, Apicella F, Cosenza A, Ferrari AR, Guerrini R, Muratori F, Romano MF, Santorelli FM, Tancredi R, Sicca F.

PLoS One. 2013 Sep 23;8(9):e75015. doi: 10.1371/journal.pone.0075015. eCollection 2013.

30.

Editorial: molecular aspects of cancer resistance to biological and non- biological drugs and strategies to overcome resistance.

Romano MF, Zambrano N.

Curr Med Chem. 2014;21(14):1567-8. No abstract available.

PMID:
23992335
31.

Cellular and molecular background underlying the diversity in therapeutic responses between primary tumours and metastases.

Romano S, D'Angelillo A, Romano A, Nappo G, Romano MF.

Curr Med Chem. 2014;21(14):1631-8. Review.

PMID:
23992331
32.

Synergy between enzastaurin doxorubicin in inducing melanoma apoptosis.

Romano S, Nappo G, Calì G, Wang SY, Staibano S, D'Angelillo A, Ilardi G, Sorrentino A, Di Pace AL, Siano M, Bisogni R, Romano MF.

Pigment Cell Melanoma Res. 2013 Nov;26(6):900-11. doi: 10.1111/pcmr.12144. Epub 2013 Aug 7.

PMID:
23866034
33.

FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential.

Romano S, Staibano S, Greco A, Brunetti A, Nappo G, Ilardi G, Martinelli R, Sorrentino A, Di Pace A, Mascolo M, Bisogni R, Scalvenzi M, Alfano B, Romano MF.

Cell Death Dis. 2013 Apr 4;4:e578. doi: 10.1038/cddis.2013.109.

34.

Tumour prevention and tumour progression: a dual role for statins?

Romano S, Romano MF.

Curr Opin Pharmacol. 2013 Apr;13(2):309-10. doi: 10.1016/j.coph.2013.02.004. Epub 2013 Mar 6. No abstract available.

35.

Increased anaerobic metabolism is a distinctive signature in a colorectal cancer cellular model of resistance to antiepidermal growth factor receptor antibody.

Monteleone F, Rosa R, Vitale M, D'Ambrosio C, Succoio M, Formisano L, Nappi L, Romano MF, Scaloni A, Tortora G, Bianco R, Zambrano N.

Proteomics. 2013 Mar;13(5):866-77. doi: 10.1002/pmic.201200303. Epub 2013 Jan 24.

PMID:
23281225
36.

Atorvastatin sensitises vascular smooth muscle cells, but not endothelial cells, to TNF-α-induced cell death.

Giordano A, Romano S, Nappo G, Messina S, Polimeno M, Corcione N, Cali G, Ferraro P, Monaco M, Zambrano N, Romano MF.

Curr Pharm Des. 2012;18(38):6331-8.

PMID:
23092297
37.

Overexpression of chromatin assembly factor-1 p60, poly(ADP-ribose) polymerase 1 and nestin predicts metastasizing behaviour of oral cancer.

Mascolo M, Ilardi G, Romano MF, Celetti A, Siano M, Romano S, Luise C, Merolla F, Rocco A, Vecchione ML, De Rosa G, Staibano S.

Histopathology. 2012 Dec;61(6):1089-105. doi: 10.1111/j.1365-2559.2012.04313.x. Epub 2012 Aug 8.

38.

Synergy between direct coronary stenting technique and use of the novel thin strut cobalt chromium Skylor™ stent: the MACE in follow up patients treated with Skylor stent [MILES Study].

Giordano A, Polimeno M, Corcione N, Fattore L, Di Lorenzo L, Biondi-Zoccai G, Ferraro P, Romano MF.

Curr Cardiol Rev. 2012 Feb;8(1):6-13.

39.

Surgical management of symptomatic simple hepatic cysts.

Amendolara M, Bucca D, Barbarino C, Romano MF, Marino G, Zucchelli M, Stevanato G, Bernardi M, Ranzato R.

G Chir. 2012 Jan-Feb;33(1-2):17-20.

PMID:
22357432
40.

The emerging role of large immunophilin FK506 binding protein 51 in cancer.

Romano S, Sorrentino A, Di Pace AL, Nappo G, Mercogliano C, Romano MF.

Curr Med Chem. 2011;18(35):5424-9. Review.

41.

Differential effect of atorvastatin and tacrolimus on proliferation of vascular smooth muscle and endothelial cells.

Giordano A, Romano S, Monaco M, Sorrentino A, Corcione N, Di Pace AL, Ferraro P, Nappo G, Polimeno M, Romano MF.

Am J Physiol Heart Circ Physiol. 2012 Jan 1;302(1):H135-42. doi: 10.1152/ajpheart.00490.2011. Epub 2011 Nov 4.

42.

Measuring the effectiveness of homeopathic care through objective and shared indicators.

Leone L, Marchitiello M, Natilli M, Romano MF.

Homeopathy. 2011 Oct;100(4):212-9. doi: 10.1016/j.homp.2011.07.002.

PMID:
21962195
43.

Overexpression of gastrokine 1 in gastric cancer cells induces Fas-mediated apoptosis.

Rippa E, La Monica G, Allocca R, Romano MF, De Palma M, Arcari P.

J Cell Physiol. 2011 Oct;226(10):2571-8. doi: 10.1002/jcp.22601.

PMID:
21792914
44.

FKBPs: opportunistic modifiers or active players in cancer?

Romano MF.

Curr Opin Pharmacol. 2011 Aug;11(4):279-80. doi: 10.1016/j.coph.2011.05.002. Epub 2011 Jun 7. No abstract available.

PMID:
21646047
45.

FKBP51 and the NF-κB regulatory pathway in cancer.

Romano S, Mallardo M, Romano MF.

Curr Opin Pharmacol. 2011 Aug;11(4):288-93. doi: 10.1016/j.coph.2011.04.011. Epub 2011 May 11. Review.

PMID:
21565553
46.

In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis.

Quintavalle C, Brenca M, De Micco F, Fiore D, Romano S, Romano MF, Apone F, Bianco A, Zabatta MA, Troncone G, Briguori C, Condorelli G.

Cell Death Dis. 2011 May 12;2:e155. doi: 10.1038/cddis.2011.38.

47.

Toxoplasma gondii Dense Granule Antigen 1 stimulates apoptosis of monocytes through autocrine TGF-β signaling.

D'Angelillo A, De Luna E, Romano S, Bisogni R, Buffolano W, Gargano N, Del Porto P, Del Vecchio L, Petersen E, Romano MF.

Apoptosis. 2011 Jun;16(6):551-62. doi: 10.1007/s10495-011-0586-0.

PMID:
21390541
48.

FK506-binding protein 51 is a possible novel tumoral marker.

Romano S, D'Angelillo A, Staibano S, Ilardi G, Romano MF.

Cell Death Dis. 2010 Jul 15;1:e55. doi: 10.1038/cddis.2010.32. No abstract available.

49.

FK506 binding proteins as targets in anticancer therapy.

Romano S, Di Pace A, Sorrentino A, Bisogni R, Sivero L, Romano MF.

Anticancer Agents Med Chem. 2010 Nov 1;10(9):651-6. Review.

PMID:
21182472
50.

Carotid intima-media thickness in asymptomatic patients with arterial hypertension without clinical cardiovascular disease: relation with left ventricular geometry and mass and coexisting risk factors.

Di Bello V, Carerj S, Perticone F, Benedetto F, Palombo C, Talini E, Giannini D, La Carrubba S, Antonini-Canterin F, Di Salvo G, Bellieni G, Pezzano A, Romano MF, Balbarini A; Research Group of the Italian Society of CardioVascular Echocardiography (SIEC).

Angiology. 2009 Dec-2010 Jan;60(6):705-13. doi: 10.1177/0003319708329337.

PMID:
20093251

Supplemental Content

Loading ...
Support Center